Innovative Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R21)

קרןNational Cancer Institute/NIH
סוגResearch Grants
תאריך אחרון27/09/2019
פקולטהEngineering, Exact Sciences, Life Sciences, Medicine

This grant solicits applications proposing exploratory research projects focused on the early-stage development of highly innovative technologies offering novel molecular or cellular analysis capabilities for basic cancer research or clinical care. Well-suited applications must offer the potential to accelerate and/or enhance research in the areas of cancer biology, early detection and screening, clinical diagnosis, treatment, control, epidemiology, and/or address issues associated with cancer health disparities.


Funding: $400,000 total 

Duration: 3 years 


Research Authority due date: 10 days prior to submission 

LOI (encouraged) due dates: 7.2.19, 28.4.19, 27.8.19

Full proposal due dates: 7.3.19, 28.5.19. 27.9.19


קבצים מצורפים
עדכון אחרוןעדכון אחרון: 08/01/2019
אוניברסיטת תל-אביב, ת.ד. 39040, תל-אביב 6997801
UI/UX Basch_Interactive